Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder

BACKGROUND: Several studies have reported the efficacy and safety of rituximab (RTX) and mycophenolate mofetil (MMF) in neuromyelitis optica spectrum disorder (NMOSD). This study aimed to evaluate the efficacy and safety of long-term use of low-dose RTX and MMF in Chinese patients with NMOSD. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jie, Xue, Binbin, Li, Jia, Zhu, Ruofan, Pan, Juyuan, Chen, Zhibo, Zhang, Xu, Li, Xiang, Xia, Junhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120916/
https://www.ncbi.nlm.nih.gov/pubmed/35599732
http://dx.doi.org/10.3389/fneur.2022.891064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120916/
https://www.ncbi.nlm.nih.gov/pubmed/35599732
http://dx.doi.org/10.3389/fneur.2022.891064

Ejemplares similares